Beckman Research Institute is a 501(c)(3) organization based in Duarte, California, registered in 2005, with $285,315,317 in FY2023 revenue. CharityIndex grades it C+, and it directs about 85% of spending to programs.
Revenue (FY2023)
$285.3M
▲ 24.5% vs prior year
Medical Research median: $217K
Expenses (FY2023)
$382.5M
Net assets
$1.2B
Employees
1,177
Rated on 4 of 4 criteria.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Beckman Research Institute: 85% to programs · $0 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Beckman Research Institute: 38 mo reserves · -34% margin earns a D on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Beckman Research Institute: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Beckman Research Institute: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To discover and translate innovative laboratory findings into new clinical treatments by using practical applications of chemistry, physics and biology.
Revenue declined from $298.9M (FY2013) to $285.3M (FY2023) across 11 reported years.
Financial snapshot
Operating margin
-34.0%
Spent more than it raised in the latest fiscal year.
Total assets
$2.2B
Total liabilities
$984.9M
Net assets
$1.2B
Salaries & benefits
$215.7M
56% of expenses
Board members
10
9 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $285,315,317▲24.5% | $382,452,556▲8.2% | $1,199,895,574▲7.3% | $2,184,814,083▲12.2% | 990 |
| 2022 | $229,086,534▼20.5% | $353,496,343▼3.8% | $1,117,975,862▼0.9% | $1,946,470,774▲10.9% | 990 |
| 2021 | $288,276,013▼15.0% | $367,599,613▲7.5% | $1,128,376,635▼22.6% | $1,755,270,549▼12.1% | 990 |
| 2020 | $339,177,936▲27.4% | $341,846,245▼7.2% | $1,458,151,495▲13.9% | $1,995,828,082▲17.9% | 990 |
| 2019 | $266,229,786▼53.2% | $368,392,601▼13.5% | $1,279,751,193▼4.2% | $1,692,642,628▲8.8% | 990 |
| 2018 | $568,398,026▼2.9% | $426,095,842▼1.8% | $1,336,326,196▲2.1% | $1,556,201,710▲5.7% | 990 |
| 2017 | $585,400,050▲17.2% | $433,936,266▲13.6% | $1,308,559,820▲15.6% | $1,472,757,241▲14.5% | 990 |
| 2016 | $499,374,736▲34.7% | $381,859,865▲16.6% | $1,131,633,686▲22.1% | $1,286,545,335▲15.5% | 990 |
| 2015 | $370,790,162▲12.1% | $327,375,925▲14.1% | $927,152,807▲10.2% | $1,113,807,258▲12.3% | 990 |
| 2014 | $330,876,359▲10.7% | $286,999,710▲8.2% | $841,571,032▼1.8% | $991,819,363▼1.1% | 990 |
| 2013 | $298,938,718 | $265,274,408▲1.4% | $857,320,134▲8.3% | $1,002,567,058▲7.8% | 990 |
| 2012 | — | $261,648,917▼0.2% | $791,522,627▲13.2% | $930,429,780▲16.4% | 990 |
| 2011 | — | $262,152,955▲9.4% | $699,064,869▲12.5% | $799,004,654▲10.2% | 990 |
| 2010 | — | $239,700,349▲9.5% | $621,324,161▼2.5% | $725,117,069▼2.0% | 990 |
| 2009 | — | $218,916,343 | $636,940,312 | $739,833,649 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Steven Terry Rosen Md — $1,562,947 (0.41% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Steven Terry Rosen Md | Evp, Dir Emeritus Comp Canc Ctr & Bri | 54 | $1,562,947 |
| Larry Kwak | Deputy Dir, Comp Cancer Ctr | 60 | $1,040,975 |
| David A Horne | Vice Prvst & Depty Dir Bri & Dn Fac Aff | 60 | $914,413 |
| Ashley Baker Lee | Svp, Research Operations | 48 | $872,074 |
| John D Carpten | Chf Sci Off, Bri Dir, Canc Ctr Dir | 33 | $571,428 |
| Debbie C Thurmond | Director/professor | 60 | $435,306 |
| David Craig | Dep Dir, Integr Transltnl Sci | 60 | $428,774 |
| Edward S Kim | Director, System Clin Trials | 15 | $396,461 |
| Jo Ann Escasa-haigh | Chief Business Officer | 12 | $365,936 |
| Harlan Alcon Levine | Pres, Hlth Innovation & Policy | 11 | $364,681 |
| Debra F Fields | Exec Vp & Chief Transformation Ofc | 12 | $340,881 |
| Jennifer Parkhurst | Former Officer | 12 | $312,857 |
| Robert W Stone | President & Ceo | 4 | $300,338 |
| Mark Hulse | Chief Digital Officer | 12 | $276,672 |
| Cristin J O'callahan | General Counsel & Corp Secretary | 10 | $186,671 |
| Philip Okala | Former Officer | 12 | $175,540 |
| Donald J Matthewson | Assistant Treasurer | 12 | $125,464 |
| Marcellus R Van Den Brink Md Phd | Pres Coh La & Nmc & Chf Phys Exec | 6 | $99,787 |
| Kristin Bertell | Chief Philanthropy Officer | 2 | $41,469 |
| Vijay Trisal Md | System Chief Clinical Officer | 2 | $37,057 |
| Contractor | Services | Paid |
|---|---|---|
| Mintz Levin Cohn Ferris Glovsky and Popeo PC | Legal Services | $2,245,000 |
| Lcs Constructors Inc | Construction Services | $1,698,367 |
| Fish & Richardson PC | Legal Services | $1,177,032 |
| Jackson Laboratory | Laboratory Services | $1,129,483 |
| Comparative Biosciences Inc | Laboratory Services | $1,023,584 |
184 grants to Beckman Research Institute totaling $2.0B, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| American Heart Association Inc | Research | 2024 | $1,714,744 |
| Breakthrough T1d | T1d research | 2024 | $1,276,538 |
| American Cancer Society Inc | Support/research | 2024 | $1,006,956 |
| Blood Cancer United Inc | Research grant | 2024 | $375,000 |
| American Diabetes Association Inc | Innovative research to tackle the epidemic of youth-onset type 2 diabetes | 2024 | $192,027 |
| Mayo Clinic Group Return | Support charitable programs | 2024 | $190,604 |
| Mayo Clinic | Support charitable programs | 2024 | $35,913 |
| Charities Aid Foundation America | Charitable donation | 2024 | $7,063 |
| City of Hope | Operating support | 2023 | $46,623,682 |
| Breakthrough T1d | T1d research | 2023 | $1,500,000 |
| American Heart Association Inc | Research | 2023 | $1,286,064 |
| Blood Cancer United Inc | Research grant | 2023 | $806,250 |
| American Cancer Society Inc | Support/research | 2023 | $474,000 |
| University of Southern California | Subaward | 2023 | $398,846 |
| American Diabetes Association Inc | Innovative clinical or translational science health disparities | 2023 | $324,188 |
1 grant totaling $1.6M in FY2023. All grants made by Beckman Research Institute →
| Recipient | Purpose | Amount |
|---|---|---|
| Translational Genomics Research Institute | Operating support | $1,633,728 |
Explore more
Data for Beckman Research Institute (EIN 95-3432210) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.